Chemoproteomic Profiling Uncovers CDK4-Mediated Phosphorylation of the Translational Suppressor 4E-BP1

Area of Science:

• Biochemistry
• Molecular Biology
• Proteomics

Background:

• The human proteome comprises ~20,000 protein-coding genes with over 145,000 known phosphosites.
• Understanding the kinases responsible for specific phosphorylation events is crucial for deciphering signaling pathways, especially in disease contexts.
• Current knowledge gaps hinder the annotation of kinases mediating post-translational modifications within the human phosphoproteome.

Purpose of the Study:

• To develop an unbiased chemoproteomic method for identifying high-confidence kinase-substrate interactions with phosphosite specificity.
• To uncover novel kinase-substrate relationships relevant to phosphorylation-driven signaling cascades.
• To elucidate the role of specific kinases in regulating cellular processes and disease states.

Main Methods:

• Development of an unbiased chemoproteomic assay.
• Application of the assay to identify kinase-substrate interactions.
• Phosphosite-specific analysis of kinase activity.

Main Results:

• Identification of cyclin-dependent kinase 4 (CDK4) as a kinase regulating cap-dependent translation.
• Demonstration that CDK4 phosphorylates the tumor suppressor 4E-BP1.
• Uncovering a novel signaling axis involving CDK4 and 4E-BP1 in translation regulation.

Conclusions:

• The developed chemoproteomic approach enables high-confidence identification of kinase-substrate interactions.
• CDK4 plays a significant role in regulating cap-dependent translation through 4E-BP1 phosphorylation.
• This finding provides insights into the mechanisms of CDK4/6 inhibitors and their effect on cell proliferation.